Skip to main content
PMC home page
Gut logoLink to Gut
. 1980 Jun;21(6):545–554. doi: 10.1136/gut.21.6.545

Renin-angiotensin-aldosterone system in cirrhosis.

S P Wilkinson, R Williams
PMCID: PMC1419648  PMID: 7000629

Abstract

According to traditional concepts, ascites formation and portal hypertension in cirrhosis lead to a deficit in the 'effective' extracellular fluid (ECF) and blood volumes respectively. The renin-angiotensin-aldosterone (RAA) system is thus stimulated and the kidneys retain fluid as a homeostatic mechanism to restore the ECF and blood volumes. Recent studies, however, show that approximately two-thirds of patients with ascites do not have a stimulated RAA system and in those without clinical evidence of fluid retention the RAA system is actually suppressed. These findings are incompatible with the concepts of reduced effective ECF and blood volumes. Despite the fact that most patients retaining sodim and accumulating ascites have a normal plasma aldosterone concentration, other evidence strongly suggests a dominant role for aldosterone in the regulation of renal sodium excretion. There might therefore be an increased renal tubular sensitivity to aldosterone in cirrhosis. For the one-third of patients with ascites who do have a stimulated RAA system this may well be a response to reduced effective ECF and/or blood volumes in accord with traditional concepts.

Full text

PDF
545

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUGUST J. T., NELSON D. H., THORN G. W. Response of normal subjects to large amounts of aldosterone. J Clin Invest. 1958 Nov;37(11):1549–1555. doi: 10.1172/JCI103747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arroyo V., Bosch J., Mauri M., Viver J., Mas A., Rivera F., Rodes J. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites. Eur J Clin Invest. 1979 Feb;9(1):69–73. doi: 10.1111/j.1365-2362.1979.tb01669.x. [DOI] [PubMed] [Google Scholar]
  3. Barnardo D. E., Summerskill W. H., Strong C. G., Baldus W. P. Renal function, renin activity and endogenous vasoactive substances in cirrhosis. Am J Dig Dis. 1970 May;15(5):419–425. doi: 10.1007/BF02283868. [DOI] [PubMed] [Google Scholar]
  4. Chonko A. M., Bay W. H., Stein J. H., Ferris T. F. The role of renin and aldosterone in the salt retention of edema. Am J Med. 1977 Dec;63(6):881–889. doi: 10.1016/0002-9343(77)90541-1. [DOI] [PubMed] [Google Scholar]
  5. Clemente C., Bosch J., Rodés J., Arroyo V., Mas A., Maragall S. Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis. Gut. 1977 Jul;18(7):556–560. doi: 10.1136/gut.18.7.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DAVIS J. O., HOLMAN J. E., CARPENTER C. C., URQUHART J., HIGGINS J. T., Jr AN EXTRA-ADRENAL FACTOR ESSENTIAL FOR CHRONIC RENAL SODIUM RETENTION IN PRESENCE OF INCREASED SODIUM-RETAINING HORMONE. Circ Res. 1964 Jan;14:17–31. doi: 10.1161/01.res.14.1.17. [DOI] [PubMed] [Google Scholar]
  7. Davis J. O., Freeman R. H. Mechanisms regulating renin release. Physiol Rev. 1976 Jan;56(1):1–56. doi: 10.1152/physrev.1976.56.1.1. [DOI] [PubMed] [Google Scholar]
  8. Denison E. K., Lieberman F. L., Reynolds T. B. 9- -fluorohydrocortisone induced ascites in alcoholic liver disease. Gastroenterology. 1971 Oct;61(4):497–503. [PubMed] [Google Scholar]
  9. EPSTEIN F. H., LESSER G. T., BERGER E. Y. Renal function in decompensated cirrhosis of the liver. Proc Soc Exp Biol Med. 1950 Dec;75(3):822–824. doi: 10.3181/00379727-75-18358. [DOI] [PubMed] [Google Scholar]
  10. Earley L. E., Orloff J. THE MECHANISM OF ANTIDIURESIS ASSOCIATED WITH THE ADMINISTRATION OF HYDROCHLOROTHIAZIDE TO PATIENTS WITH VASOPRESSIN-RESISTANT DIABETES INSIPIDUS. J Clin Invest. 1962 Nov;41(11):1988–1997. doi: 10.1172/JCI104657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eggert R. C. Spironolactone diuresis in patients with cirrhosis and ascites. Br Med J. 1970 Nov 14;4(5732):401–403. doi: 10.1136/bmj.4.5732.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Epstein M., Berk D. P., Hollenberg N. K., Adams D. F., Chalmers T. C., Abrams H. L., Merrill J. P. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med. 1970 Aug;49(2):175–185. doi: 10.1016/s0002-9343(70)80073-0. [DOI] [PubMed] [Google Scholar]
  13. Epstein M., Levinson R., Sancho J., Haber E., Re R. Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res. 1977 Dec;41(6):818–829. doi: 10.1161/01.res.41.6.818. [DOI] [PubMed] [Google Scholar]
  14. Fitzsimons J. T., Simons B. J. The effect on drinking in the rat of intravenous infusion of angiotensin, given alone or in combination with other stimuli of thirst. J Physiol. 1969 Jul;203(1):45–57. doi: 10.1113/jphysiol.1969.sp008848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. GIUSEFFI J., WERK E. E., Jr, LARSON P. U., SCHIFF L., ELLIOTT D. W. Effect of bilateral adrenalectomy in a patient with massive ascites and postnecrotic cirrhosis. N Engl J Med. 1957 Oct 24;257(17):796–803. doi: 10.1056/NEJM195710242571702. [DOI] [PubMed] [Google Scholar]
  16. Gutman R. A., Forrey A. W., Fleet W. P., Cutler R. E. Vasopressor-induced natriuresis and altered intrarenal haemodynamics in cirrhotic man. Clin Sci. 1973 Jul;45(1):19–34. doi: 10.1042/cs0450019. [DOI] [PubMed] [Google Scholar]
  17. HENLEY K. S., STREETEN D. H., POLLARD H. M. Hyperaldo-steronism in liver disease. The treatment of refractory ascites by adrenalectomy and by the administration of spirolactones. Gastroenterology. 1960 May;38:681–689. [PubMed] [Google Scholar]
  18. Hollenberg N. K., Williams G. H., Burger B., Ishikawa I., Adams D. F. Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. J Clin Invest. 1976 Jan;57(1):39–46. doi: 10.1172/JCI108266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. KONTOS H. A., SHAPIRO W., MAUCK H. P., PATTERSON J. L., Jr GENERAL AND REGIONAL CIRCULATORY ALTERATIONS IN CIRRHOSIS OF THE LIVER. Am J Med. 1964 Oct;37:526–535. doi: 10.1016/0002-9343(64)90066-x. [DOI] [PubMed] [Google Scholar]
  20. Klingler E. L., Jr, Vaamonde C. A., Vaamonde L. S., Lancestremere R. G., Morosi H. J., Frisch E., Papper S. Renal function changes in cirrhosis of the liver. A prospective study. Arch Intern Med. 1970 Jun;125(6):1010–1015. [PubMed] [Google Scholar]
  21. Laragh J. H., Cannon P. J., Bentzel C. J., Sicinski A. M., Meltzer J. I. ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES. J Clin Invest. 1963 Jul;42(7):1179–1192. doi: 10.1172/JCI104803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Levy M. Sodium retention and ascites formation in dogs with experimental portal cirrhosis. Am J Physiol. 1977 Dec;233(6):F572–F585. doi: 10.1152/ajprenal.1977.233.6.F572. [DOI] [PubMed] [Google Scholar]
  23. Lieberman F. L., Reynolds T. B. Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure. J Clin Invest. 1967 Aug;46(8):1297–1308. doi: 10.1172/JCI105622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liehr H., Grün M., Brunswig D., Sautter T. Endotoxinämie bei Leberzirrhose. Z Gastroenterol. 1976 Jan;14(1):14–23. [PubMed] [Google Scholar]
  25. Lévy V. G., Opolon P., Pauleau N., Caroli J. Treatment of ascites by reinfusion of concentrated peritoneal fluid--review of 318 procedures in 210 patients. Postgrad Med J. 1975 Aug;51(598):564–566. doi: 10.1136/pgmj.51.598.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. MARSON F. G. Total adrenalectomy in hepatic cirrhosis with ascites. Lancet. 1954 Oct 23;267(6843):847–848. doi: 10.1016/s0140-6736(54)91936-4. [DOI] [PubMed] [Google Scholar]
  27. MILIES E. A new diuretic factor of hepatic origin. Acta Physiol Lat Am. 1960;10:178–193. [PubMed] [Google Scholar]
  28. MURRAY J. F., DAWSON A. M., SHERLOCK S. Circulatory changes in chronic liver disease. Am J Med. 1958 Mar;24(3):358–367. doi: 10.1016/0002-9343(58)90322-x. [DOI] [PubMed] [Google Scholar]
  29. McNay J. L., Abe Y. Pressure-dependent heterogeneity of renal cortical blood flow in dogs. Circ Res. 1970 Oct;27(4):571–587. doi: 10.1161/01.res.27.4.571. [DOI] [PubMed] [Google Scholar]
  30. REEVES G., LOWENSTEIN L. M., PHIL D., SOMMERS S. C. THE MACULA DENSA AND JUXTAGLOMERULAR BODY IN CIRRHOSIS. Arch Intern Med. 1963 Nov;112:708–715. doi: 10.1001/archinte.1963.03860050095010. [DOI] [PubMed] [Google Scholar]
  31. Rector J. B., Stein J. H., Bay W. H., Osgood R. W., Ferris T. F. Effect of hemorrhage and vasopressor agents on distribution of renal blood flow. Am J Physiol. 1972 May;222(5):1125–1131. doi: 10.1152/ajplegacy.1972.222.5.1125. [DOI] [PubMed] [Google Scholar]
  32. Reynolds T. B., Lieberman F. L., Redeker A. G. Functional renal failure with cirrhosis. The effect of plasma expansion therapy. Medicine (Baltimore) 1967 Mar;46(2):191–196. doi: 10.1097/00005792-196703000-00011. [DOI] [PubMed] [Google Scholar]
  33. SHEAR L., KLEINERMAN J., GABUZDA G. J. RENAL FAILURE IN PATIENTS WITH CIRRHOSIS OF THE LIVER. I. CLINICAL AND PATHOLOGIC CHARACTERISTICS. Am J Med. 1965 Aug;39:184–198. doi: 10.1016/0002-9343(65)90041-0. [DOI] [PubMed] [Google Scholar]
  34. Sachs H., Share L., Osinchak J., Carpi A. Capacity of the neurohypophysis to release vasopressin. Endocrinology. 1967 Oct;81(4):755–770. doi: 10.1210/endo-81-4-755. [DOI] [PubMed] [Google Scholar]
  35. Schroeder E. T., Anderson G. H., Goldman S. H., Streeten D. H. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Kidney Int. 1976 Jun;9(6):511–519. doi: 10.1038/ki.1976.65. [DOI] [PubMed] [Google Scholar]
  36. Schroeder E. T., Eich R. H., Smulyan H., Gould A. B., Gabuzda G. J. Plasma renin level in hepatic cirrhosis. Relaton to functional renal failure. Am J Med. 1970 Aug;49(2):186–191. doi: 10.1016/s0002-9343(70)80074-2. [DOI] [PubMed] [Google Scholar]
  37. Sealey J. E., Laragh J. H. Further studies of a natriuretic substance occurring in human urine and plasma. Circ Res. 1971 May;28(5 Suppl):32–43. doi: 10.1161/01.res.28.5.ii-32. [DOI] [PubMed] [Google Scholar]
  38. Shear L., Ching S., Gabuzda G. J. Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med. 1970 Jun 18;282(25):1391–1396. doi: 10.1056/NEJM197006182822502. [DOI] [PubMed] [Google Scholar]
  39. THOMPSON D. D., PITTS R. F. Effects of alterations of renal arterial pressure on sodium and water excretion. Am J Physiol. 1952 Feb;168(2):490–499. doi: 10.1152/ajplegacy.1952.168.2.490. [DOI] [PubMed] [Google Scholar]
  40. Tarao K., Moroi T., Nagakura Y., Ikeuchi T., Suyama T., Endo O., Fukushima K. Relationship between endotoxaemia and protein concentration of ascites in cirrhotic patients. Gut. 1979 Mar;20(3):205–210. doi: 10.1136/gut.20.3.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Traverso H. D., Raynaud C., Blanchon P., Roberti A., Vesin P., Viguie R., Kellershohn C. Etude des clearances de l'inuline et du PAH, du débit cardiaque, du Na et du K échangeables et des liquides extracellulaires, au cours de l'évolution de la cirrhose du foie. Rev Int Hepatol. 1966;16(8):1377–1398. [PubMed] [Google Scholar]
  42. Trippodo N. C., Hall J. E., Lohmeier T. E., Guyton A. C. Intrarenal role of angiotensin II in controlling sodium excretion during dehydration in dogs. Clin Sci Mol Med. 1977 May;52(5):545–548. doi: 10.1042/cs0520545. [DOI] [PubMed] [Google Scholar]
  43. Vecsei P., Düsterdieck G., Jahnecke J., Lommer D., Wolff H. P. Secretion and turnover of aldosterone in various pathological states. Clin Sci. 1969 Apr;36(2):241–256. [PubMed] [Google Scholar]
  44. WOLFF H. P., KOCZOREK K. R., BUCHBORN E. Aldosterone and antidiuretic hormone (adiuretin) in liver disease. Acta Endocrinol (Copenh) 1958 Jan;27(1):45–58. doi: 10.1530/acta.0.0270045. [DOI] [PubMed] [Google Scholar]
  45. Wernze H., Spech H. J., Müller G. Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. Klin Wochenschr. 1978 Apr 15;56(8):389–397. doi: 10.1007/BF01477293. [DOI] [PubMed] [Google Scholar]
  46. Wilkinson S. P., Bernardi M., Smith I. K., Jowett T. P., Slater J. D., Williams R. Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites. Gastroenterology. 1977 Oct;73(4 Pt 1):659–663. [PubMed] [Google Scholar]
  47. Wilkinson S. P., Davidson A. R., Henderson J., Williams R. Ascites reinfusion using Rhodiascit apparatus--clinical experience and coagulation abnormalities. Postgrad Med J. 1975 Aug;51(598):583–587. doi: 10.1136/pgmj.51.598.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wilkinson S. P., Hirst D., Day D. W., Williams R. Spectrum of renal tubular damage in renal failure secondary to cirrhosis and fulminant hepatic failure. J Clin Pathol. 1978 Feb;31(2):101–107. doi: 10.1136/jcp.31.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wilkinson S. P., Jowett T. P., Slater J. D., Arroyo V., Moodie H., Williams R. Renal sodium retention in cirrhosis: relation to aldosterone and nephron site. Clin Sci (Lond) 1979 Feb;56(2):169–177. doi: 10.1042/cs0560169. [DOI] [PubMed] [Google Scholar]
  50. Wilkinson S. P., Moodie H., Alam A., Williams R. Renal retention of sodium in cirrhosis and fulminant hepatic failure. Postgrad Med J. 1975 Aug;51(598):527–531. doi: 10.1136/pgmj.51.598.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wilkinson S. P., Moodie H., Stamatakis J. D., Kakkar V. V., Williams R. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J. 1976 Dec 11;2(6049):1415–1418. doi: 10.1136/bmj.2.6049.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wilkinson S. P., Smith I. K., Clarke M., Arroyo V., Richardson J., Moodie H., Williams R. Intrarenal distribution of plasma flow in cirrhosis as measured by transit renography: relationship with plasma renin activity, and sodium and water excretion. Clin Sci Mol Med. 1977 May;52(5):469–475. doi: 10.1042/cs0520469. [DOI] [PubMed] [Google Scholar]
  53. Wilkinson S. P., Smith I. K., Moodie H., Poston L., Williams R. Studies on mineralocorticoid 'escape' in cirrhosis. Clin Sci (Lond) 1979 May;56(5):401–406. doi: 10.1042/cs0560401. [DOI] [PubMed] [Google Scholar]
  54. Wilkinson S. P., Smith I. K., Williams R. Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis. Hypertension. 1979 Mar-Apr;1(2):125–129. doi: 10.1161/01.hyp.1.2.125. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES